Adamis Pharmaceuticals Receives Notice of Allowance for US and Japanese Patents for Its Dry Powder Inhaler

By: via Benzinga
Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) ("Company") recently received a notice of allowance that one of its patent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.